Research mainly focused on the production of homogeneously polymodified antibody drug conjugates for use in oncology. Utilisation of a branched chemical linkers/bioorthogonal chemistry to achieve these aims and understand potential drug synergies. In addition to this area of research the lab is also interested in the development of novel small molecule/targeted anti-fungal and anti-bacterial agents.